Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor-mediated mitophagy: An emerging therapeutic target in acute kidney injury
Neha Dagar, Ajinath Kale, Stefanie Steiger, et al.
Mitochondrion (2022) Vol. 66, pp. 82-91
Closed Access | Times Cited: 24

Showing 24 citing articles:

Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation
Yingying Lü, Zhijia Li, Shuangqian Zhang, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 736-766
Open Access | Times Cited: 285
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease
Hsin‐Jung Ho, Hitoshi Shirakawa
Cells (2022) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 115
Mitophagy for cardioprotection
Allen Sam Titus, Eun‐Ah Sung, Daniela Zablocki, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 49
Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Free Radical Research (2024) Vol. 58, Iss. 2, pp. 69-87
Closed Access | Times Cited: 11
Molelcuar regulation of mitophagy signaling in tumor microenvironment and its targeting for cancer therapy
Bishnu Prasad Behera, Soumya Ranjan Mishra, Srimanta Patra, et al.
Cytokine & Growth Factor Reviews (2025)
Closed Access | Times Cited: 1
Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress
Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar, et al.
Cell Biology International (2025)
Closed Access | Times Cited: 1
A comparative analysis of drug-induced kidney injury adverse reactions between cyclosporine and tacrolimus based on the FAERS database
Min Xu, Shanggang Xu, Xun Yi
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
TRPA1 protects against contrast-induced renal tubular injury by preserving mitochondrial dynamics via the AMPK/DRP1 pathway
Xinquan Wang, Tao Luo, Yi Yang, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 5
The role of mitochondrial dysfunction in kidney injury and disease
Xueqian Jia, Lifu Zhu, Qixing Zhu, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103576-103576
Closed Access | Times Cited: 4
Mitochondrial dysfunction in acute kidney injury
Congcong Yao, Ziwei Li, Keke Sun, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 4
Ambra1 in exosomes secreted by HK-2 cells damaged by supersaturated oxalate induce mitophagy and autophagy-ferroptosis in normal HK-2 cells to participate in the occurrence of kidney stones
Xiaozhe Su, Chao Song, Ziqi He, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1871, Iss. 1, pp. 119604-119604
Open Access | Times Cited: 10
Dietary phytosterol supplementation mitigates renal fibrosis via activating mitophagy and modulating the gut microbiota
Fan Yang, Yingjie Gao, Siyi Xie, et al.
Food & Function (2025)
Open Access
Esculetin and Phloretin Combination Mitigates Acute Kidney Injury‐Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual‐Pronged Approach
Neha Dagar, Tahib Habshi, Vishwadeep Shelke, et al.
Phytotherapy Research (2025)
Closed Access
Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases
Mark Makarov, Eduard Korkotian
Toxins (2023) Vol. 15, Iss. 3, pp. 202-202
Open Access | Times Cited: 9
Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction
Jiewu Huang, Ye Liang, Lili Zhou
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 321, pp. 121643-121643
Closed Access | Times Cited: 9
A Pacific Oyster-Derived Antioxidant, DHMBA, Protects Renal Tubular HK-2 Cells against Oxidative Stress via Reduction of Mitochondrial ROS Production and Fragmentation
Hsin‐Jung Ho, Natsumi Aoki, Yi-Jou Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10061-10061
Open Access | Times Cited: 9
Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity
Neha Dagar, Hemant R. Jadhav, Anil Bhanudas Gaikwad
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 1-19
Closed Access | Times Cited: 3
Recent Advances of Mitochondrial Alterations in Alzheimer’s Disease: A Perspective of Mitochondrial Basic Events
Wenyan Wei, Ying Jiang, Guizhen Hu, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. 2, pp. 379-396
Closed Access | Times Cited: 3
Inhibition of Usp14 ameliorates renal ischemia-reperfusion injury by reducing Tfap2a stabilization and facilitating mitophagy
Yang Li, Bo‐Qing Dong, Ying Wang, et al.
Translational research (2024) Vol. 270, pp. 94-103
Closed Access | Times Cited: 2
The multifaceted effects of mitochondria in kidney diseases
Jia-Le Xue, Jialing Ji, Yan Zhou, et al.
Mitochondrion (2024) Vol. 79, pp. 101957-101957
Closed Access | Times Cited: 2
Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis
Xiujuan Qin, Huiyu Chen, Xiaoli Zhu, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1120-1134
Open Access | Times Cited: 5
Iron chelators as mitophagy agents: Potential and limitations
Tereza Brogyányi, Zdeněk Kejík, Kamila Veselá, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117407-117407
Open Access | Times Cited: 1
Management of inflammaging in kidney diseases: focusing on the current investigational drugs
Vishwadeep Shelke, Neha Dagar, Maciej Lech, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1153-1166
Closed Access
Page 1

Scroll to top